Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 866.43M P/E - EPS this Y -46.70% Ern Qtrly Grth -
Income -66.07M Forward P/E -36.73 EPS next Y 106.80% 50D Avg Chg 13.00%
Sales 124.46M PEG -0.53 EPS past 5Y - 200D Avg Chg 27.00%
Dividend N/A Price/Book 7.15 EPS next 5Y 30.00% 52W High Chg -21.00%
Recommedations 1.40 Quick Ratio 4.09 Shares Outstanding 232.69M 52W Low Chg 453.00%
Insider Own 1.95% ROA -16.22% Shares Float 226.69M Beta 0.82
Inst Own 60.33% ROE -49.84% Shares Shorted/Prior 35.02M/33.61M Price 4.04
Gross Margin 57.15% Profit Margin -53.09% Avg. Volume 5,148,887 Target Price 13.55
Oper. Margin -81.44% Earnings Date May 1 Volume 10,175,200 Change 5.21%
About Ardelyx, Inc.

Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to reduce serum phosphorus in adults with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among patients with kidney and/or heart failure; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Ardelyx, Inc. News
04/02/24 The Millionaire’s Shortcut: 3 Stocks to Transform Your Portfolio This Month
03/28/24 Ardelyx, Inc. Reports Employment Inducement Grants
03/25/24 Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
03/21/24 Institutional investors may overlook Ardelyx, Inc.'s (NASDAQ:ARDX) recent US$195m market cap drop as long-term gains remain positive
03/16/24 The Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter
02/28/24 The Millionaire’s Watchlist: 3 Stocks Set for a Meteoric Rise
02/27/24 Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
02/27/24 Stocks on the Launchpad: The Next 3 Market Sensations
02/23/24 Ardelyx, Inc. (NASDAQ:ARDX) Q4 2023 Earnings Call Transcript
02/22/24 Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say
02/22/24 Ardelyx (ARDX) Reports Q4 Loss, Lags Revenue Estimates
02/22/24 Ardelyx Inc (ARDX) Reports Robust Revenue Growth and Strategic Advances in 2023
02/22/24 Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
02/20/24 Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know
02/19/24 Analyst Upgrades: 3 Stocks Predicted to Soar In Q2 2024
02/19/24 3 Revolutionary Biotech Stocks Poised for 10X Surge
02/15/24 Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
02/09/24 Wall Street Analysts Believe Ardelyx (ARDX) Could Rally 34.84%: Here's is How to Trade
02/09/24 Ardelyx (ARDX) Is a Great Choice for 'Trend' Investors, Here's Why
02/08/24 3 Unstoppable Russell 2000 to Buy in February
ARDX Chatroom

User Image Minister_Maud Posted - 7 minutes ago

$ARDX sit on your hands and chill, buy a few more perhaps, relax. Never invest more than you can afford to lose

User Image Rowinn Posted - 33 minutes ago

$ARDX SHORTS ARE FRUSTRADED AS MUCH AS WE ARE. They cant get the stock price down fast enough even though they are throwing everything but the kitchen at us before ER. They have the Middleast crisis and higher rates for longer and they STILL cant do better than$6.50 by Option Friday 4/19. Even if they manage another 50 cent drop by4/26 down to $6 they are screwed. I also foresee enough price support between $6.50 and $6 to slow the Shorts down. Imagine if they hadnt had the Crisis and the Rates? They still would be in the $7 struggle bus. MAJOR OPPORTUNITY LOSS FOR THE SHORTS! THEY SCREWED UP BY NOT DEEPLY DRIVING DOWN THE SP PRICE RIGHT AT THE START OF THE CRISIS AND INSTEAD THEY JUST LETT IT HAPPEN ON THE CHEAP! DOOM IS COMING FOR THEM BUT IS MAJOR OPPORTUNITY FOR US TO ACCUMULATE!

User Image ISEEITALLTHETIME Posted - 1 hour ago

$ARDX Hey Kadams18, why would the self righteous Bernard, buy 1000 shares tomorrow? He is above everybody else, in his own mind.

User Image ISEEITALLTHETIME Posted - 1 hour ago

$ARDX This has only been down about 25 out of the last 30 trading days. Maybe you should wait until it gets to $3.

User Image RagingBullll Posted - 1 hour ago

$ARDX Watching. Waiting. Buying. Price drop is a blessing in disguise. Been wanting to add more for a while. Get em while they are cheap.

User Image Kadams18 Posted - 1 hour ago

$ARDX Everyone here buy 1,000 shares tomorrow let’s boost this shit back up

User Image scdorsey22 Posted - 2 hours ago

$ARDX last year stock took a 35% dive from the April open at 4.91 before it consolidated for months in that 3-5ish range. We are sitting at just above -30% since March open right now. Given the macro environment somewhere in the 30-40% seems normal to me for a major RSI reset before the revenue story on X starts to play out in the coming quarters. Anything below that seems like it would have to be a negative company catalyst. People on here are hurting after seeing the slow grind of death lately and starting to search for explanations but there has been zero indication the company isn’t executing in fashion similar to its already proven success with ISB. I have separate allotments here at lower price points but for this new one I’ve been accumulating, an average in the 6’s sounds like a gift to me

User Image bernardbaruch Posted - 2 hours ago

$ARDX bot a little more AH $6.49

User Image GainIntoxication Posted - 2 hours ago

$ARDX The recent price action reminds me of Provention Bio last year around this time (dropped ~30% on a slow walk-down), with similar pricing (add in the recent hiring of an M&A guy)...means nothing necessarily, other than I sold the Friday before the BO last time - not doing that again.

User Image Bluefin1976 Posted - 3 hours ago

$ARDX make that 6.48 after hours

User Image Bluefin1976 Posted - 3 hours ago

$ARDX 6.49 after hours. They are going to try to get this under $6 by Friday’s close.

User Image SocioCobb Posted - 3 hours ago

$ARDX Sooooooo close. Lying in wait for my strike. Tomorrow? Godspeed bulls!

User Image CrollSprings Posted - 3 hours ago

$ARDX Someone got instructions to come out of the woodwork. You know who you are.

User Image opportoni Posted - 3 hours ago

$ARDX This is back to the odd situation where Xphozah comes for free. With the increased expectations for Ibsrela, the IBS-C indication alone justifies a market cap of 2 billion and more. Absolutely irrational and dysfunctional markets. I have put all I have in here and wait for things to get back to normal.

User Image ISEEITALLTHETIME Posted - 3 hours ago

$ARDX Sure you did Bernard.....

User Image bernardbaruch Posted - 4 hours ago

$ARDX bot a little at $6.54 AH

User Image ISEEITALLTHETIME Posted - 4 hours ago

$ARDX Where is Bernard's punk ass? I think you are a shill.

User Image gerrard87 Posted - 4 hours ago

$ARDX its funny that big boys not buying on this so called stupid low levels....they know more and waiting for another -30% or there is no interest at all because of limited TAM, peak sales, bundling problem or competition. Just no interest (low volumen) speaks for itself. Dont say its macro condition and rates.... still no no brainer on this level. I see a support at $5.8 (not a real chart guy!). so maybe before ER we will hit it. Many bagholders are born the last 6 weeks here

User Image Bluefin1976 Posted - 5 hours ago

$ARDX And why is it that ARDX’s percentage loss is always double that of XBI???

User Image Bluefin1976 Posted - 5 hours ago

$ARDX Look at the options. There’s a reason there are 4k puts at 7.50 for January 2025.

User Image Bluefin1976 Posted - 5 hours ago

$ARDX To all those who talked crap when I said this would be in the 6’s this week… 🖕

User Image Bluefin1976 Posted - 5 hours ago

$ARDX 6.55 close. This is just getting stupid good for the shorts.

User Image bankrupt_bob Posted - 5 hours ago

$ARDX …adding 7K shares at $6.55

User Image Rowinn Posted - 5 hours ago

$ARDX Much ado about nothing!. Tomororrow is another great day to buy. Accumulate! This should be the bottom at $6.50 if we have no further drone shoot outs!

User Image ISEEITALLTHETIME Posted - 5 hours ago

$ARDX Sorry guys, this isn't acting like a promising up and coming stock, with two blockbuster drugs on the market.

User Image opportoni Posted - 5 hours ago

$ARDX

User Image 1stGenS10 Posted - 5 hours ago

$ARDX I mean it's just funny at this point, isn't it?

User Image Rowinn Posted - 5 hours ago

$ARDX Next week is last week before ER. Expecting buy orders if we croos $6.50.

User Image Pharoh42 Posted - 5 hours ago

$ARDX -20% in one month , hopefully we pick up some pace soon

User Image Gaucho12 Posted - 5 hours ago

$ARDX You should expect this attack. The shorts will drive down the price to try to limit the upswing price after Q1 news.

Analyst Ratings
Wedbush Outperform Apr 17, 24
Leerink Partners Outperform Apr 5, 24
Piper Sandler Overweight Feb 23, 24
Wedbush Outperform Feb 23, 24
Wedbush Outperform Jan 12, 24
Citigroup Buy Jan 10, 24
Raymond James Strong Buy Jan 9, 24
Raymond James Strong Buy Dec 18, 23
Wedbush Outperform Dec 1, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rosenbaum David P. Chief Development Of.. Chief Development Officer Jan 08 Sell 6.64 30,000 199,200 286,596 01/10/24
Renz Justin A Chief Financial Offi.. Chief Financial Officer Dec 26 Sell 6.36 225,000 1,431,000 182,426 12/28/23
Renz Justin A Chief Financial Offi.. Chief Financial Officer Dec 26 Option 0.99 75,000 74,250 407,426 12/28/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Dec 18 Sell 6.07 5,675 34,447 316,596 12/20/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Dec 14 Sell 5.55 7,000 38,850 322,271 12/15/23
GRAMMER ELIZABETH A See Remarks See Remarks Dec 11 Sell 5.0785 50,000 253,925 275,675 12/13/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Dec 08 Sell 5.2738 20,000 105,476 329,271 12/08/23
Williams Laura A Chief Medical Office.. Chief Medical Officer Nov 20 Sell 4.3622 2,581 11,259 266,191 11/22/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Nov 20 Sell 4.36 3,767 16,424 113,293 11/22/23
Rodriguez Susan Chief Commercial Off.. Chief Commercial Officer Nov 20 Sell 4.3622 4,714 20,563 346,973 11/22/23
Renz Justin A Chief Financial Offi.. Chief Financial Officer Nov 20 Sell 4.3622 2,873 12,533 332,426 11/22/23
RAAB MICHAEL President & CEO President & CEO Nov 20 Sell 4.3622 11,368 49,589 867,868 11/22/23
GRAMMER ELIZABETH A See Remarks See Remarks Nov 20 Sell 4.3622 2,384 10,399 325,675 11/22/23
Felsch Robert Ora See Remarks See Remarks Nov 20 Sell 4.3622 1,044 4,554 117,066 11/22/23
Blanks Robert See Remarks See Remarks Nov 20 Sell 4.3622 2,835 12,367 260,453 11/22/23
Williams Laura A Chief Medical Office.. Chief Medical Officer Nov 15 Sell 3.9999 25,000 99,998 266,839 11/17/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Oct 10 Sell 4 1,644 6,576 365,378 10/12/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Sep 08 Sell 4.55 2,897 13,181 367,022 09/12/23
Williams Laura A Chief Medical Office.. Chief Medical Officer Jun 27 Sell 3.3453 25,000 83,632 294,430 06/29/23
Blanks Robert See Remarks See Remarks Jun 23 Sell 3.63 33,333 120,999 266,134 06/27/23
Blanks Robert See Remarks See Remarks Jun 23 Option 3.42 33,333 113,999 299,467 06/27/23
Rosenbaum David P. Chief Development Of.. Chief Development Officer Mar 29 Sell 4.6293 3,000 13,888 113,096 03/31/23
Felsch Robert Ora See Remarks See Remarks Aug 31 Buy .6188 3,000 1,856 91,418 09/01/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Aug 31 Buy 0.62 3,000 1,860 92,369 09/01/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Aug 31 Sell 0.92 3,000 2,760 89,369 09/01/22
Renz Justin A Chief Financial Offi.. Chief Financial Officer Aug 31 Buy 0.6188 3,000 1,856 263,549 09/01/22
Williams Laura A Chief Medical Office.. Chief Medical Officer Aug 31 Buy 0.6188 3,000 1,856 245,441 09/01/22
RAAB MICHAEL President & CEO President & CEO Aug 31 Buy 0.6188 3,000 1,856 665,680 09/01/22
GRAMMER ELIZABETH A See Remarks See Remarks Aug 31 Buy 0.6188 3,000 1,856 256,110 09/01/22
Rodriguez Susan Chief Commercial Off.. Chief Commercial Officer Aug 22 Sell 0.98 3,420 3,352 286,173 08/24/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Aug 22 Sell 0.98 1,955 1,916 89,369 08/24/22
Blanks Robert See Remarks See Remarks Aug 22 Sell 0.98 1,458 1,429 317,669 08/24/22
RAAB MICHAEL President & CEO President & CEO Aug 22 Sell 0.98 6,146 6,023 662,680 08/24/22
GRAMMER ELIZABETH A See Remarks See Remarks Aug 22 Sell 0.98 1,236 1,211 253,110 08/24/22
Williams Laura A Chief Medical Office.. Chief Medical Officer Aug 22 Sell 0.98 1,276 1,250 242,441 08/24/22
Renz Justin A Chief Financial Offi.. Chief Financial Officer Aug 22 Sell 0.98 1,498 1,468 260,549 08/24/22
Renz Justin A Chief Financial Offi.. Chief Financial Officer Jun 06 Sell 0.64 73,312 46,920 262,047 06/08/22
Rodriguez Susan Chief Commercial Off.. Chief Commercial Officer Jun 06 Sell 0.64 43,920 28,109 289,593 06/08/22
Blanks Robert See Remarks See Remarks Jun 06 Sell 0.64 73,312 46,920 324,315 06/08/22
GRAMMER ELIZABETH A See Remarks See Remarks Jun 06 Sell 0.64 60,821 38,925 254,346 06/08/22
Rosenbaum David P. Chief Development Of.. Chief Development Officer Jun 06 Sell 0.64 61,640 39,450 89,866 06/08/22
RAAB MICHAEL President & CEO President & CEO Jun 06 Sell 0.64 103,624 66,319 668,826 06/08/22
Blanks Robert See Remarks See Remarks Feb 22 Sell 0.67 1,752 1,174 399,116 02/25/22
SANDELL SCOTT D 10% Owner 10% Owner Dec 09 Sell 1.32 2,881,570 3,803,672 2,258,850 12/27/21
BASKETT FOREST 10% Owner 10% Owner Dec 09 Sell 1.32 2,881,570 3,803,672 2,258,850 12/27/21
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15 Option 2.32 42,000 97,440 113,527 12/15/20
GRAMMER ELIZABETH A See Remarks See Remarks Dec 15 Sell 7.3 42,000 306,600 72,527 12/15/20